Peter Wipf

45PUBLICATIONS
83CO-AUTHORS
Organometallic chemistryMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 20, 2026
Cycloaddition Reactions of Sulfo-Biginelli Derived Thiadiazines.

|Sep 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic.

Keertana Yalamanchili, Mark Broadwin, Dwight D Harris

|Jul 03, 2025
Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric Inhibitors.

Neal Green, Matthew G LaPorte, William Paquette

|Jan 21, 2025
OGG1 and MUTYH repair activities promote telomeric 8-oxoguanine induced senescence in human fibroblasts.

Mariarosaria De Rosa, Ryan P Barnes, Ariana C Detwiler

|Jan 08, 2025
JP4-039 Mitigates Cisplatin-Induced Acute Kidney Injury by Inhibiting Oxidative Stress and Blocking Apoptosis and Ferroptosis in Mice.

Merlin Airik, Kacian Clayton, Peter Wipf

|Dec 05, 2024
Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria.

Junjie Zhu, Fu-Ying Qin, Saifei Lei

Pageof 8

Frequent Collaborators

4 joint publications

Donna M Huryn

3 joint publications

Tsui-Fen Chou

3 joint publications

Matteo Borgini

3 joint publications

Joel S Greenberger